z-logo
open-access-imgOpen Access
Anticyclic Citrullinated Protein Antibodies Are Implicated in the Development of Cardiovascular Disease in Rheumatoid Arthritis
Author(s) -
Nuria Barbarroja,
C. PérezSánchez,
P. RuizLimón,
Carmen Castro,
M. Á. Aguirre,
R.M. Carretero,
P. Segui,
Yolanda Jiménez,
Manuela Sanna,
Antonio RodríguezAriza,
Eduardo CollantesEstévez,
Alejandro EscuderoContreras,
C. López-Pedrera
Publication year - 2014
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.114.304475
Subject(s) - medicine , autoantibody , oxidative stress , proinflammatory cytokine , rheumatoid arthritis , immunology , inflammation , antibody , arthritis
Previous studies have suggested a relationship between anticyclic citrullinated protein (CCP) levels and development of cardiovascular disease in rheumatoid arthritis (RA). However, a limited number of studies have demonstrated an involvement of anti-CCPs in those processes. This study was aimed to define the specific role of these auto-antibodies in the pro-oxidative, inflammatory, and proatherogenic profile observed in leukocytes from RA patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom